Skip to main navigation
logo

Investor Relations

  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Management
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Shareholder Services
    • Email Alerts
    • Contact IR
    • RSS Feeds

News Releases

11 Jan '22
Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available in the Optum Store
Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store expands access to this unique testing option amidst a surge of US COVID-19 cases caused by
10 Jan '22
Lucira Health Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 and Provides Business Update
EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced preliminary revenue results for the

Investor Tools

  • Print Page
  • RSS Feeds
  • Email Page
  • Email Alerts

© 2022 Lucira Health, Inc. All rights reserved.

  • Facebook
  • Twitter
  • LinkedIn
  • Google+